Market Tracker

06/30 3:42pm ET
5.19
BATS BZX Real-Time Price
As of 3:37pm ET
 +0.05 / +0.97%
Today’s Change
5.01
Today|||52-Week Range
9.35
-17.49%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close5.14
Today’s open5.15
Day’s range5.15 - 5.28
Volume266,408
Average volume (3 months)378,087
Market cap$215.5M
Dividend yield--
Data as of 3:26pm ET, 06/30/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,058.97%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.45%
P/E ratioNM
Price/Sales3.73
Price/Book1.05

Competitors

 Today’s
change
Today’s
% change
OCATOcata Therapeutics I...+0.20+3.97%
STMLStemline Therapeutic...+0.24+2.08%
NVLSNivalis Therapeutics...+0.10+0.67%
GTXIGTX Inc-0.05-3.25%
Data as of 3:39pm ET, 06/30/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$70.4M
Annual profit (last year)$5.5M
Net profit margin7.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts